The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks

Clinical trial NCT05816538 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05816538
Sponsor: University of Rijeka
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Paravertebral Block Pectoralis and Serratus Plane Nerve Blocks Breast Cancer Immunologic Suppression Levobupivacaine

Start date: 2024-01-18
Primary completion: 2025-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.